Arcutis biotherapeutics stock.

66.61%. Get the latest Arcutis Biotherapeutics Inc (ARQT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...--Arcutis Biotherapeutics, Inc., ... today reported the grant of an aggregate of 90,500 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 106,500 ...These awards were approved by the Compensation Committee of Arcutis’ Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of March 01, 2023, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).The stock options have a ten-year term and an exercise price of $1.99 per share, equal to the per share closing price of Arcutis’ common stock as reported by …

ARQT Stock Chart & Stats Advanced Chart > -74.69% Day’s Range $0 - $0 52-Week Range $1.77 - $18.19 Previous Close $2.03 Volume 1.23M Average Volume (3M) 2.25M …

Aug 3, 2022 · In addition, Arcutis has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock at the public offering price, less underwriting discounts and ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is an early commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with ...WESTLAKE VILLAGE, Calif., May 09, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported financial results for the quarter ended March 31, 2023, and provided a business …These 8 analysts have an average price target of $25.62 versus the current price of Arcutis Biotherapeutics at $2.49, implying upside. Below is a summary of how these 8 analysts rated Arcutis ...1 thg 2, 2021 ... Stock of Arcutis Biotherapeutics, a Westlake Village-based company developing dermatological treatments, shot up more than 30% on Feb.Arcutis Biotherapeutics, Inc. (ARQT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong …

WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the pricing of its underwritten public offering of common …

Dec 1, 2023 · See the latest Arcutis Biotherapeutics Inc Ordinary Shares stock price (ARQT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Just Reported, And Analysts Assigned A US$41.57 Price Target. (Simply Wall St.) Aug-10-23 08:16AM. Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia. (GlobeNewswire) Aug-09-23 09:23AM.Arcutis Biotherapeutics Inc ARQT. Arcutis Biotherapeutics announced the pricing of a $100 million public offering of 32.5 million common shares at $2.50 per share. The company has a 52-week low of ...Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Arcutis Biotherapeutics, Inc. (ARQT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.Mar 9, 2021 · The Arcutis Biotherapeutics stock prediction for 2025 is currently $ 1.777134, assuming that Arcutis Biotherapeutics shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -12.46% increase in the ARQT stock price. Mizuho Securities analyst Uy Ear maintained a Buy rating on Arcutis Biotherapeutics ( ARQT – Research Report) today and set a price target of $61.00. The company’s shares opened today at $13. ...Currently, Arcutis Biotherapeutics has an average volume of 1.07M. Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is negative on the stock.

As of September 1, 2023, Arcutis Biotherapeutics Inc’s stock price is $8.96, which is up 4.92% from its previous closing price. At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and ...February 28, 2023 at 4:02 PM · 11 min read. Arcutis Biotherapeutics, Inc. Achieved net revenues of $3.0 million for ZORYVE® (roflumilast) cream 0.3% in the first full quarter since the August ...Latest News. November 15, 2022. Get Arcutis Biotherapeutics Inc (ARQT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Oct. 9, 2023, 08:27 AM Sean Kim PhD, an analyst from JonesTrading, reiterated the Buy rating on Arcutis Biotherapeutics ( ARQT – Research Report ). The associated price target is $44.00. Sean...Dec 1, 2023 · See the latest Arcutis Biotherapeutics Inc Ordinary Shares stock price (ARQT:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Mar 9, 2021 · The Arcutis Biotherapeutics stock prediction for 2025 is currently $ 1.777134, assuming that Arcutis Biotherapeutics shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -12.46% increase in the ARQT stock price.

Currently, Arcutis Biotherapeutics has an average volume of 1.07M. Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is negative on the stock.Shares of Arcutis Biotherapeutics ... The healthcare company's stock closed last week at $8.96 a share and fell to as low as $7.47 on Thursday after Arcutis reported trial data regarding a ...

According to 6 analyst offering 12-month price targets in the last 3 months, Arcutis Biotherapeutics has an average price target of $42.17 with a high of $57.00 and a low of $22.00.Arcutis Biotherapeutics Inc. Watch list Set a price target alert Open Last Updated: Dec 1, 2023 1:02 p.m. EST Real time quote $ 1.9450 0.1050 5.71% Previous Close $1.8400 …Arcutis Biotherapeutics, Inc. Common Stock (ARQT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.As of May 30, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $7.81. Arcutis Biotherapeutics Inc is down 7.02% from its previous closing price of $8.40. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $8.11 and $8.57. Currently, there are 61.17 million shares of Arcutis Biotherapeutics Inc ...Dec 1, 2023 · 9 analysts have issued twelve-month target prices for Arcutis Biotherapeutics' shares. Their ARQT share price targets range from $6.00 to $57.00. On average, they anticipate the company's stock price to reach $29.67 in the next year. This suggests a possible upside of 1,390.8% from the stock's current price. Shares of Arcutis Biotherapeutics ... The healthcare company's stock closed last week at $8.96 a share and fell to as low as $7.47 on Thursday after Arcutis reported trial data regarding a ...WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (“Arcutis”) (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the pricing of its underwritten public offering of 7,500,000 shares of its common stock ...Arcutis Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ARQT updated stock price target summary.

Mar 9, 2021 · The Arcutis Biotherapeutics stock prediction for 2025 is currently $ 1.777134, assuming that Arcutis Biotherapeutics shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -12.46% increase in the ARQT stock price.

About Arcutis . Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions. With a commitment to solving the most persistent patient challenges in dermatology, Arcutis …

Since the trade, Arcutis Biotherapeutics Inc's stock has declined by 20.89%, and it has plummeted by 91.54% since its IPO. The year-to-date performance is also down by 86.8%. With no applicable GF ...Mar 22, 2023 · As of March 22, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $10.86. Arcutis Biotherapeutics Inc is down 6.06% from its previous closing price of $11.56. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $11.04 and $11.91. Currently, there are 61.04 million shares of Arcutis ... The latest price target for Arcutis Biotherapeutics ( NASDAQ: ARQT) was reported by Morgan Stanley on Monday, November 13, 2023. The analyst firm set a price target for 10.00 expecting ARQT to ...Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is an early commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with ...Arcutis Biotherapeutics, Inc. (ARQT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong …About Arcutis Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions. ... negative effects of this announcement or the consummation of the proposed acquisition on the …Aug 8, 2023 · Arcutis Biotherapeutics, Inc. (ARQT) came out with a quarterly loss of $1.16 per share versus the Zacks Consensus Estimate of a loss of $1.22. Arcutis Biotherapeutics Inc’s Stock Price as of Market Close. As of March 06, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $14.54. Arcutis Biotherapeutics Inc is down 6.5% from its previous closing price of $15.55. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $15.55 and $16.45.In addition, Arcutis has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of Arcutis’ common stock at the public offering price less the underwriting discounts and commissions. ... Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and ...

5 thg 9, 2023 ... What Caused Arcutis Biotherapeutics Inc Stock's Price to Dip? Stock prices are primarily based on seller supply and buyer demand. But have you ...Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is an early commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of patients living with ...WESTLAKE VILLAGE, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 90,500 restricted stock units of Arcutis’ common …Find the latest Arcutis Biotherapeutics, Inc. (ARQT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Instagram:https://instagram. pre market most activestocks less than dollar10crocks stock2 year treasury yield symbol Arcutis Biotherapeutics Inc ARQT. Arcutis Biotherapeutics announced the pricing of a $100 million public offering of 32.5 million common shares at $2.50 per share. The company has a 52-week low of ... fha mortgage rates azcryptocurrencies strategies In a report released today, Sean Kim PhD from JonesTrading reiterated a Buy rating on Arcutis Biotherapeutics ( ARQT – Research Report ), with a price target of $44.00. The company’s shares ...66.61%. Get the latest Arcutis Biotherapeutics Inc (ARQT) real-time quote, historical performance, charts, and other financial information to help you make more informed … natural gas companies stocks Nov 30, 2023 · Arcutis Announces Pricing of $100 Million Public Offering. WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage biopharmaceutical company focused on developing meaningf... 4 weeks ago - GlobeNewsWire. Shares of Arcutis Biotherapeutics ( ARQT -3.16%) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology ...